Member Login
  1. Stocks
    2. /
  2. Knight Therapeutics Inc. (TSX: GUD)
    3. /

TSX:GUD (Knight Therapeutics Inc.)

About GUD

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Knight Therapeutics Inc. (TSX: GUD) Latest News

    Rocket lift off through the clouds
    Dividend Stocks

    3 TSX Stocks Ready to Explode in Value

    | Christopher Liew, CFA

    These stocks in rate-sensitive sectors could seriously break out after the rate cut.

    Read more »

    A doctor takes a patient's blood pressure in a clinical office.
    Dividend Stocks

    TSX Healthcare in April 2024: The Best Stocks to Buy Right Now

    | Christopher Liew, CFA

    TSX’s healthcare sector is not as popular as the heavyweight sectors, but it has three of the best stocks you…

    Read more »

    Stocks for Beginners

    2 Healthcare Stocks You Can Buy and Hold for the Next Decade

    | Amy Legate-Wolfe

    These two healthcare stocks are showing strong signs of growth for the next decade and are already improving by leaps…

    Read more »

    Dividend Stocks

    3 Growth Stocks to Invest $1,000 in Right Now

    | Christopher Liew, CFA

    Canadians can invest $1,000 in three growth stocks that are well-positioned to deliver far superior returns.

    Read more »

    Dividend Stocks

    2 Top Pharmaceutical Stocks to Buy on the TSX Today

    | Adam Othman

    Consider investing in these two TSX stocks if you want exposure to the pharmaceutical industry’s performance on the Canadian stock…

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    4 Biotech Stocks That Could Break Through the Market

    | Christopher Liew, CFA

    Four TSX biotech stocks could deliver outsized gains in 2023, as they are poised to break through the market soon.

    Read more »

    lab worker inspects test tubes
    Dividend Stocks

    3 Biotech Stocks to Buy Before the Down Market Is Over

    | Christopher Liew, CFA

    Biotech stocks are high-risk, high-reward investments, although three names are buying opportunities in the current down market.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    This Biotech Stock Could Offer Big Growth – Even During a Recession

    | Chris MacDonald

    Here's why Knight Therapeutics (TSX:GUD) is one biotech stock that's worth a buy, or at least a look, in this…

    Read more »

    Stocks for Beginners

    2 Health Care Stocks Could Return at Least 50% in 1 Year

    | Christopher Liew, CFA

    The health care sector continues to underperform, although two stocks could deliver superior returns in one year.

    Read more »

    Investing

    Can the Healthcare Sector Rebound in 2022?

    | Adam Othman

    Despite the overall downfall of the healthcare sector (weighed down by marijuana companies), there are stocks that might display strong…

    Read more »

    Investing

    Strong Buy Ratings: 2 Healthcare Stocks With More Than 40% Upside

    | Christopher Liew, CFA

    The healthcare sector has two constituents that could deliver more than 40% in capital gains. Invest in WELL Health Technologies…

    Read more »

    Coronavirus

    Forget Trillium Therapeutics Stock (TSX:TRIL): Buy These Pharma Stocks Instead!

    | Amy Legate-Wolfe

    Motley Fool investors who want in on a pharma rebound should definitely look into these stocks over Trillium Therapeutics stock…

    Read more »